Correlation Between Akero Therapeutics and Scynexis
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Scynexis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Scynexis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Scynexis, you can compare the effects of market volatilities on Akero Therapeutics and Scynexis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Scynexis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Scynexis.
Diversification Opportunities for Akero Therapeutics and Scynexis
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Akero and Scynexis is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Scynexis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scynexis and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Scynexis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scynexis has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Scynexis go up and down completely randomly.
Pair Corralation between Akero Therapeutics and Scynexis
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 1.3 times more return on investment than Scynexis. However, Akero Therapeutics is 1.3 times more volatile than Scynexis. It trades about 0.08 of its potential returns per unit of risk. Scynexis is currently generating about 0.04 per unit of risk. If you would invest 3,070 in Akero Therapeutics on August 31, 2024 and sell it today you would earn a total of 147.00 from holding Akero Therapeutics or generate 4.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akero Therapeutics vs. Scynexis
Performance |
| Timeline |
| Akero Therapeutics |
| Scynexis |
Akero Therapeutics and Scynexis Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and Scynexis
The main advantage of trading using opposite Akero Therapeutics and Scynexis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Scynexis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scynexis will offset losses from the drop in Scynexis' long position.| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |